ARKG vs SCHX
ARK Genomic Revolution ETF vs Schwab US Large-Cap ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHX—
Schwab US Large-Cap ETF
Low-cost US large-cap exposure.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHX |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHX top holdings
Holdings data unavailable for SCHX.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHX
SCHX (Schwab US Large-Cap ETF) is Low-cost US large-cap exposure.